BIOFIL CHEM & PHARMA LTD Financial Ratios
BIOFILCHEM · Healthcare · Current price ₹32.05
P/E ratio
94.3x
P/B ratio
2.5x
ROE
3.0%
ROCE
4.1%
Debt / Equity
0.03
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 94.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 3.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 4.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.03 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with BIOFIL CHEM & PHARMA LTD's latest numbers.
BIOFIL CHEM & PHARMA LTD profitability
BIOFIL CHEM & PHARMA LTD generates a return on equity of 3.0% and a return on capital employed of 4.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.03 and a P/E of 94.3x, BIOFIL CHEM & PHARMA LTD is conservatively financed. Our overall business-quality score for the company is 3.1 / 10.
Understand the ratios
More on BIOFIL CHEM & PHARMA LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.